Celldex Therapeutics, Inc. to Present at Inaugural Cancer Immunotherapy Conference

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the Company will be presenting at the Cancer Immunotherapy: A Long-Awaited Reality conference taking place on October 21, 2010, at the New York Academy of Medicine in New York.
MORE ON THIS TOPIC